Skip to main content
OpenTrials

Clinical trial condition

X-Linked Intellectual Disability

Explore clinical trials studying X-Linked Intellectual Disability. Study availability and eligibility vary by location and protocol.

271 public trials 52 recruiting studies
Refine in advanced search Browse all conditions

X-Linked Intellectual Disability trial results

Completed

Safety and Efficacy of Hunterase

NCT01645189

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +17 more
Locations
  • Samsug Medical Center Seoul, South Korea
View Trial Details
Completed

Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001

NCT00823368

Conditions
Chromosome Disorders, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Southwest Autism Research & Resource Center Phoenix, Arizona, United States
  • University of California-Los Angeles Neuropsychiatric Institute Los Angeles, California, United States
  • M.I.N.D. Institute Sacramento, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
View Trial Details
Completed

Efficacy and Safety Study of STX209 (Arbaclofen) for the Treatment of Social Withdrawal in Children With Fragile X Syndrome

NCT01325220

Conditions
Chromosome Disorders, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Southwest Autism Research & Resource Center Phoenix, Arizona, United States
  • Miller Children's Hospital Long Beach, California, United States
  • University of California-Davis, M.I.N.D. Institute Sacramento, California, United States
  • Psychiatric Centers at San Diego San Diego, California, United States
View all 28 locations
View Trial Details
Completed

Biomarker and DNA Collection in Subjects Participating in Protocol 22003

NCT00892580

Conditions
Chromosome Disorders, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Southwest Autism Research & Resource Center Phoenix, Arizona, United States
  • University of California-Los Angeles Neuropsychiatric Institute Los Angeles, California, United States
  • Yale Child Study Center New Haven, Connecticut, United States
  • Riley Hospital for Children Indianapolis, Indiana, United States
View Trial Details
Completed

Efficacy and Safety Study of STX209 (Arbaclofen) for Social Withdrawal in Adolescents and Adults With Fragile X Syndrome

NCT01282268

Conditions
Autism Spectrum Disorder, Child Development Disorders, Pervasive, Chromosome Disorders, +14 more
Locations
  • Southwest Autism Research & Resource Center Phoenix, Arizona, United States
  • Miller Children's Hospital Research Administration Long Beach, California, United States
  • University of California-Davis, M.I.N.D. Institute Sacramento, California, United States
  • Psychiatric Centers at San Diego San Diego, California, United States
View all 24 locations
View Trial Details
Completed

Safety, Tolerability and Efficacy Study of STX209 in Subjects With Fragile X Syndrome

NCT00788073

Conditions
Chromosome Disorders, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
Locations
  • Southwest Autism Research & Resource Center Phoenix, Arizona, United States
  • University of California-Los Angeles Neuropsychiatric Institute Los Angeles, California, United States
  • M.I.N.D. Institute Sacramento, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
View Trial Details

Related conditions